"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
CCK-8 Trial Feedback Form (Tongji Medical College Affiliated Hospital, Huazhong University of Science and Technology)